Skip to main content

FDA Premarket Approval: Process of Approving Ansaid as a Drug

HRD-92-85 Published: Apr 07, 1992. Publicly Released: Apr 07, 1992.
Jump To:
Skip to Highlights

Highlights

Pursuant to a congressional request, GAO reviewed the Food and Drug Administration's (FDA) process for granting premarket approval for a nonsteroidal, anti-inflammatory drug primarily sold to treat arthritis symptoms, focusing on: (1) whether the manufacturing company delayed preparing and submitting its new drug application; and (2) the company's allegations that the FDA approval process period was excessive.

Full Report

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs

Public Inquiries

Topics

Consumer protectionData collectionDrugsFood and drug lawMarketingPatentsPharmacological researchRegulatory agenciesSafety regulationDrug approvals